MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma D Skiriute, P Vaitkiene, V Saferis, V Asmoniene, K Skauminas, VP Deltuva, ... BMc cancer 12, 1-9, 2012 | 82 | 2012 |
High CHI3L1 expression is associated with glioma patient survival G Steponaitis, D Skiriutė, A Kazlauskas, I Golubickaitė, R Stakaitis, ... Diagnostic pathology 11, 1-8, 2016 | 63 | 2016 |
Glioma malignancy-dependent NDRG2 gene methylation and downregulation correlates with poor patient outcome D Skiriutė, G Steponaitis, P Vaitkienė, M Mikučiūnas, K Skauminas, ... Journal of Cancer 5 (6), 446, 2014 | 38 | 2014 |
Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma D Skiriutė, P Vaitkienė, V Ašmonienė, G Steponaitis, VP Deltuva, ... Journal of neuro-oncology 113, 441-449, 2013 | 38 | 2013 |
High level of Sema3C is associated with glioma malignancy P Vaitkienė, D Skiriutė, G Steponaitis, K Skauminas, A Tamašauskas, ... Diagnostic Pathology 10, 1-8, 2015 | 28 | 2015 |
MMP2 is associated with glioma malignancy and patient outcome R Sincevičiūtė, P Vaitkienė, R Urbanavičiūtė, G Steponaitis, ... International Journal of Clinical and Experimental Pathology 11 (6), 3010, 2018 | 27 | 2018 |
Associations Between TFPI-2 Methylation and Poor Prognosis in Glioblastomas Paulina Vaitkienė, Daina Skiriutė, Kęstutis Skauminas P Vaitkienė, D Skiriutė, K Skauminas, A Tamašauskas Medicina 48 (7), 51, 2012 | 27 | 2012 |
GFAP expression is influenced by astrocytoma grade and rs2070935 polymorphism M Sereika, R Urbanaviciute, A Tamasauskas, D Skiriute, P Vaitkiene Journal of Cancer 9 (23), 4496, 2018 | 23 | 2018 |
GATA4 and DcR1 methylation in glioblastomas P Vaitkienė, D Skiriutė, K Skauminas, A Tamašauskas Diagnostic pathology 8, 1-5, 2013 | 21 | 2013 |
Significance of amphiregulin (AREG) for the outcome of low and high grade astrocytoma patients G Steponaitis, A Kazlauskas, D Skiriute, P Vaitkiene, K Skauminas, ... Journal of Cancer 10 (6), 1479, 2019 | 19 | 2019 |
Signal transducer and activator of transcription 3 (STAT3) promoter methylation and expression in pituitary adenoma I Valiulyte, G Steponaitis, D Skiriute, A Tamasauskas, P Vaitkiene BMC Medical Genetics 18, 1-7, 2017 | 14 | 2017 |
The Role of CASC2 and miR-21 Interplay in Glioma Malignancy and Patient Outcome D Skiriute, R Stakaitis, G Steponaitis, A Tamasauskas, P Vaitkiene International journal of molecular sciences 21 (21), 7962, 2020 | 13 | 2020 |
Association of miR-34a expression with quality of life of glioblastoma patients: a prospective study P Vaitkiene, A Pranckeviciene, R Stakaitis, G Steponaitis, A Tamasauskas, ... Cancers 11 (3), 300, 2019 | 13 | 2019 |
Does MMP‐9 Gene Polymorphism Play a Role in Pituitary Adenoma Development? B Glebauskiene, R Liutkeviciene, A Vilkeviciute, L Kriauciuniene, ... Disease Markers 2017 (1), 5839528, 2017 | 12 | 2017 |
Testin (TES) as a candidate tumour suppressor and prognostic marker in human astrocytoma G Steponaitis, A Kazlauskas, D Skiriute, I Valiulyte, K Skauminas, ... Oncology Letters 12 (5), 3305-3311, 2016 | 12 | 2016 |
Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq R Krusnauskas, R Stakaitis, G Steponaitis, K Almstrup, P Vaitkiene Epigenetics 18 (1), 2163365, 2023 | 11 | 2023 |
Unique interplay between molecular miR-181b/d biomarkers and health related quality of life score in the predictive glioma models R Stakaitis, A Pranckeviciene, G Steponaitis, A Tamasauskas, ... International journal of molecular sciences 21 (20), 7450, 2020 | 11 | 2020 |
Identification of astrocytoma blood serum protein profile P Vaitkiene, R Urbanaviciute, P Grigas, G Steponaitis, A Tamasauskas, ... Cells 9 (1), 16, 2019 | 9 | 2019 |
MMP-14 and TGFβ-1 methylation in pituitary adenomas K Ruskyte, R Liutkevicienė, A Vilkeviciute, P Vaitkiene, I Valiulytė, ... Oncology Letters 12 (4), 3013-3017, 2016 | 9 | 2016 |
Oncosuppressive role of RUNX3 in human astrocytomas G Steponaitis, A Kazlauskas, P Vaitkienė, VP Deltuva, M Mikuciunas, ... Journal of Oncology 2019 (1), 1232434, 2019 | 8 | 2019 |